Modification on ligand binding to TXA2/PGH2 receptors by diethylpyrocarbonate.
Schrör
K
K
Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston 29425, USA.
Davis-Bruno
K
K
Halushka
P V
PV
D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid / Q000494:pharmacology; D001792:Blood Platelets / Q000502:physiology*; D001643:Bridged Bicyclo Compounds / Q000378:metabolism; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000378:metabolism; D004047:Diethyl Pyrocarbonate / Q000494:pharmacology*; D005229:Fatty Acids, Monounsaturated / Q000378:metabolism; D005231:Fatty Acids, Unsaturated / Q000378:metabolism; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology; D066298:In Vitro Techniques; D007457:Iodine Radioisotopes; D007700:Kinetics; D011869:Radioligand Assay; D011982:Receptors, Prostaglandin / Q000187:drug effects / Q000302:isolation & purification / Q000378:metabolism*; D017482:Receptors, Thromboxane / Q000187:drug effects / Q000302:isolation & purification / Q000378:metabolism*; D044244:Receptors, Thromboxane A2, Prostaglandin H2
D001643:Bridged Bicyclo Compounds; D019086:Bridged Bicyclo Compounds, Heterocyclic; D005229:Fatty Acids, Monounsaturated; D005231:Fatty Acids, Unsaturated; D006834:Hydrazines; D007457:Iodine Radioisotopes; D011982:Receptors, Prostaglandin; D017482:Receptors, Thromboxane; D044244:Receptors, Thromboxane A2, Prostaglandin H2; C061750:7-(3-(3-hydroxy-4-(4'-iodophenoxy)-1-butenyl)-7-oxabicyclo(2.2.1)heptan-2-yl)-5-heptenoic acid; C076030:7-(6,6-dimethyl-3-(4-iodobenzenesulfonylamino)bicyclo(3.1.1.)hept-2-yl)-5-heptenoic acid; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; C045749:SQ 29548; D004047:Diethyl Pyrocarbonate